​

MediWound (MDWD) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

MDWD Stock Forecast

MediWound (MDWD) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $31.00, with a high of $31.00 and a low of $31.00. This represents a 69.68% increase from the last price of $18.27.

$10 $15 $20 $25 $30 $35 High: $31 Avg: $31 Low: $31 Last Closed Price: $18.27

MDWD Stock Rating

MediWound stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 13 Strong Sell Sell Hold Buy Strong Buy

MDWD Price Target Upside V Benchmarks

TypeNameUpside
StockMediWound69.68%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$35.00
Last Closing Price$18.27$18.27$18.27
Upside/Downside--91.57%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2524---6
Sep, 2524---6
Aug, 2524---6
Jul, 2524---6
Jun, 2524---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 22, 2025Swayampakula RamakanthH.C. Wainwright$31.00$20.3452.41%69.68%
Feb 28, 2025Craig-Hallum$39.00$16.60134.94%113.46%
Oct 11, 2024Swayampakula RamakanthH.C. Wainwright$28.00$16.9265.48%53.26%
May 29, 2024Francois BriseboisOppenheimer$36.00$16.01124.86%97.04%
Jan 04, 2023H.C. Wainwright$23.00$13.2973.06%25.89%
Dec 30, 2022Cowen & Co.$25.00$13.4985.32%36.84%
Dec 22, 2022Maxim Group$25.00$11.01127.07%36.84%
Nov 16, 2022H.C. Wainwright$0.79$0.24229.17%-95.68%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 22, 2025H.C. WainwrightBuyBuyhold
Feb 28, 2025Craig-HallumBuyinitialise
Oct 11, 2024H.C. WainwrightBuyBuyhold
Sep 17, 2024Cowen & Co.BuyBuyhold
Aug 05, 2024Cowen & Co.BuyBuyhold
May 29, 2024OppenheimerOutperformOutperformhold
Dec 30, 2022Cowen & Co.OutperformOutperformhold
Dec 22, 2022Maxim GroupBuyinitialise
Dec 21, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.47$-3.48$-3.93$-0.75-----
Avg Forecast$-2.73$-3.43$-2.02$-0.80$-3.32$-2.24$-1.44$-0.01$1.64
High Forecast$-2.67$-3.36$-1.89$-0.53$-3.23$-1.83$-1.11$0.41$1.80
Low Forecast$-2.81$-3.54$-2.17$-0.96$-3.45$-2.68$-1.87$-0.43$1.53
Surprise %-9.52%1.46%94.55%-6.25%-----

Revenue Forecast

$15M $35M $55M $75M $95M $115M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$21.76M$23.76M$26.50M$18.69M-----
Avg Forecast$20.68M$23.85M$21.53M$18.67M$20.18M$25.35M$31.58M$64.47M$102.83M
High Forecast$21.16M$24.41M$22.74M$19.12M$20.87M$27.22M$31.58M$64.47M$110.41M
Low Forecast$20.35M$23.47M$20.48M$17.95M$19.83M$24.00M$31.58M$64.47M$97.36M
Surprise %5.26%-0.37%23.04%0.11%-----

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.60M$-13.55M$-19.60M$-6.72M-----
Avg Forecast$-11.44M$-30.94M$-12.54M$-6.72M$-30.08M$-22.96M$-15.95M$236.00K$14.78M
High Forecast$-9.15M$-30.30M$-10.03M$-5.37M$-29.09M$-16.46M$-10.00M$3.65M$16.20M
Low Forecast$-13.73M$-31.88M$-15.05M$-8.06M$-31.07M$-24.19M$-16.85M$-3.83M$13.76M
Surprise %-16.08%-56.20%56.29%------

MDWD Forecast FAQ

Is MediWound stock a buy?

MediWound stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MediWound is a favorable investment for most analysts.

What is MediWound's price target?

MediWound's price target, set by 13 Wall Street analysts, averages $31 over the next 12 months. The price target range spans from $31 at the low end to $31 at the high end, suggesting a potential 69.68% change from the previous closing price of $18.27.

How does MediWound stock forecast compare to its benchmarks?

MediWound's stock forecast shows a 69.68% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for MediWound over the past three months?

  • October 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MediWound’s EPS forecast?

MediWound's average annual EPS forecast for its fiscal year ending in December 2024 is $-3.32, marking a 342.67% increase from the reported $-0.75 in 2023. Estimates for the following years are $-2.24 in 2025, $-1.44 in 2026, $-0.01 in 2027, and $1.64 in 2028.

What is MediWound’s revenue forecast?

MediWound's average annual revenue forecast for its fiscal year ending in December 2024 is $20.18M, reflecting a 8.02% increase from the reported $18.69M in 2023. The forecast for 2025 is $25.35M, followed by $31.58M for 2026, $64.47M for 2027, and $102.83M for 2028.

What is MediWound’s net income forecast?

MediWound's net income forecast for the fiscal year ending in December 2024 stands at $-30.081M, representing an 347.90% increase from the reported $-6.716M in 2023. Projections indicate $-22.956M in 2025, $-15.949M in 2026, $236K in 2027, and $14.78M in 2028.